Description
A modulator of sickle hemoglobin; increases HbS affinity for oxygen (EC50s = 8.2 and 415 μM for purified HbS and whole blood from sickle cell anemia patients, respectively); delays oxygen release from and polymerization of HbS in a concentration-dependent manner; increases red blood cell half-life and reduces sickling ex vivo in whole blood isolated from a murine model of sickle cell anemia
Formal name: 2-hydroxy-6-[[2-[1-(1-methylethyl)-1H-pyrazol-5-yl]-3-pyridinyl]methoxy]-benzaldehyde
Synonyms: Voxelotor
Molecular weight: 337.4
CAS: 1446321-46-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cardiovascular System|Blood|Erythrocytes & Hemoglobin